Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00240045
What this trial is testing

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Who this might be right for
Type 2 Hepatorenal SyndromeRefractory Ascites
University of Alberta 9
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Not applicableLooking for participantsNCT06689670
What this trial is testing

Needle-based Percutaneous Ablation of Liver Tumors.

Who this might be right for
Liver TumorsHCC - Hepatocellular CarcinomaMetastatic Liver Tumor
inTumo Therapeutics, Inc. 31
Not applicableStudy completedNCT02335073
What this trial is testing

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
General Hospital of Shenyang Military Region 108
Post-approval studies (Phase 4)Study completedNCT02058173
What this trial is testing

"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"

Who this might be right for
Hepatitis C Virus
Shiraz University of Medical Sciences 10
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Large-scale testing (Phase 3)Study completedNCT02584283
What this trial is testing

Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation

Who this might be right for
Liver FailureEnd Stage Liver DiseaseBiliary Tract Diseases
Robert J. Porte 157
Testing effectiveness (Phase 2)Ended earlyNCT00319683
What this trial is testing

ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Adherex Technologies, Inc.
Not applicableUnknownNCT04136405
What this trial is testing

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

Who this might be right for
Hepatitis C Virus Infection, Past or PresentChronic Hepatitis c
ANRS, Emerging Infectious Diseases 3,300
Not applicableUnknownNCT03865966
What this trial is testing

Hepatitis B Virus Infection After Liver Transplantation in Children

Who this might be right for
Hepatitis B Infection
Qiu Li 100
Early research (Phase 1)UnknownNCT02652351
What this trial is testing

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Who this might be right for
Hepatic Cirrhosis
Shenzhen Hornetcorn Bio-technology Company, LTD 20
Not applicableStudy completedNCT01371396
What this trial is testing

Effect of Dietary Macronutrient Composition

Who this might be right for
Metabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesity
University of Texas Southwestern Medical Center 24
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Early research (Phase 1)Study completedNCT05586386
What this trial is testing

Cherries Role in Gut Microbiota-liver-brain Function

Who this might be right for
Obesity
Texas A&M University 60
Not applicableUnknownNCT04694573
What this trial is testing

Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies

Who this might be right for
Covid19Kidney Transplant; ComplicationsKidney Transplant Failure and Rejection+2 more
Heidelberg University 600
Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Not applicableStudy completedNCT05868005
What this trial is testing

Delivering a Multi-disease Screening Tool to Migrant Populations

Who this might be right for
HivHepatitis BHepatitis C+7 more
Barcelona Institute for Global Health 980
Early research (Phase 1)UnknownNCT05353894
What this trial is testing

Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

Who this might be right for
Primary Liver Cancer
Genoscience Pharma 27
Not applicableStudy completedNCT02647294
What this trial is testing

Polyunsaturated Fatty Acids in Patients With NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 60
Next Page